Skip to Main Content
Mu Lab
YSM Home

INFORMATION FOR

Diseases of the Nervous System, Phase III

A Study of Nipocalimab Administered to Adults With Generalized Myasthenia Gravis

What is the purpose of this trial?

The purpose of this study is to evaluate the efficacy and safety of nipocalimab compared to placebo in participants with generalized myasthenia gravis (gMG).

  • Ages
    18 years and older
  • Gender
    Both
Find out more about who can participate in this trial

Contact Information

For more information about this study, including how to volunteer, contact Richard Nowak

Help Us Discover!

You can help our team find trials you might be eligible for by creating a volunteer profile in MyChart. To get started, create a volunteer profile, or contact helpusdiscover@yale.edu, or call 877.978.8343 for more information.

Create a volunteer profile

Principal Investigator

Sub-Investigator

  • Last Updated
    10/08/2024
  • Study HIC
    #2000031341